147 related articles for article (PubMed ID: 11306013)
1. Co-administration of adenovirus vector expressing CTLA4-Ig prolongs transgene expression in the brain of mice sensitized with adenovirus.
Uchida T; Kajiwara K; Ideguchi M; Yoshikawa K; Morioka J; Suzuki M
Brain Res; 2001 Apr; 898(2):272-80. PubMed ID: 11306013
[TBL] [Abstract][Full Text] [Related]
2. Local adenovirus-mediated CTLA4-immunoglobulin expression suppresses the immune responses to adenovirus vectors in the brain.
Ideguchi M; Kajiwara K; Yoshikawa K; Uchida T; Ito H
Neuroscience; 2000; 95(1):217-26. PubMed ID: 10619478
[TBL] [Abstract][Full Text] [Related]
3. Transient inhibition of CD28 and CD40 ligand interactions prolongs adenovirus-mediated transgene expression in the lung and facilitates expression after secondary vector administration.
Wilson CB; Embree LJ; Schowalter D; Albert R; Aruffo A; Hollenbaugh D; Linsley P; Kay MA
J Virol; 1998 Sep; 72(9):7542-50. PubMed ID: 9696851
[TBL] [Abstract][Full Text] [Related]
4. Prolonged survival of xenograft fetal cardiomyocytes by adenovirus-mediated CTLA4-Ig expression.
Li TS; Hamano K; Kajiwara K; Nishida M; Zempo N; Esato K
Transplantation; 2001 Dec; 72(12):1983-5. PubMed ID: 11773899
[TBL] [Abstract][Full Text] [Related]
5. Effect of administration of CTLA4-Ig as protein or cDNA on corneal allograft survival.
Comer RM; King WJ; Ardjomand N; Theoharis S; George AJ; Larkin DF
Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):1095-103. PubMed ID: 11923251
[TBL] [Abstract][Full Text] [Related]
6. Co-injection of adenovirus expressing CTLA4-Ig prolongs adenovirally mediated lacZ reporter gene expression in the mouse retina.
Ali RR; Reichel MB; Byrnes AP; Stephens CJ; Thrasher AJ; Baker D; Hunt DM; Bhattacharya SS
Gene Ther; 1998 Nov; 5(11):1561-5. PubMed ID: 9930310
[TBL] [Abstract][Full Text] [Related]
7. Constitutive expression of murine CTLA4Ig from a recombinant adenovirus vector results in prolonged transgene expression.
Schowalter DB; Meuse L; Wilson CB; Linsley PS; Kay MA
Gene Ther; 1997 Aug; 4(8):853-60. PubMed ID: 9338015
[TBL] [Abstract][Full Text] [Related]
8. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig.
Bonham CA; Peng L; Liang X; Chen Z; Wang L; Ma L; Hackstein H; Robbins PD; Thomson AW; Fung JJ; Qian S; Lu L
J Immunol; 2002 Sep; 169(6):3382-91. PubMed ID: 12218160
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated beta-galactosidase gene delivery to the liver leads to protein deposition in kidney glomeruli.
Zhu G; Nicolson AG; Zheng XX; Strom TB; Sukhatme VP
Kidney Int; 1997 Oct; 52(4):992-9. PubMed ID: 9328938
[TBL] [Abstract][Full Text] [Related]
10. Modified AdCTLA-4 vector blocks alloimmune response in vitro.
Zamir G; Gelman AE; Debonera F; Hardwigsen J; Que X; Aldeguer X; Martin M; Shaked A; Olthoff KM
J Surg Res; 2001 May; 97(2):155-8. PubMed ID: 11341792
[TBL] [Abstract][Full Text] [Related]
11. Evidence that the adenoviral vector containing the CTLA4-Ig gene improves transgene expression and graft survival.
Namii Y; Hayashi S; Yokoyama I; Kobayashi T; Yasutomi M; Nagasaka T; Uchida K; Hamada H; Takagi H
Transplant Proc; 1997 May; 29(3):1738-9. PubMed ID: 9142255
[No Abstract] [Full Text] [Related]
12. Long-term acceptance of allografts by in vivo gene transfer of regulatable adenovirus vector containing CTLA4IgG and loxP.
Takehara M; Murakami M; Inobe M; Tanaka K; Chikuma S; Saito I; Kanegae Y; Yasunami Y; Nakano M; Yamashita K; Todo S; Uede T
Hum Gene Ther; 2001 Mar; 12(4):415-26. PubMed ID: 11242533
[TBL] [Abstract][Full Text] [Related]
13. A non-immunogenic adenoviral vector, coexpressing CTLA4Ig and bilirubin-uridine-diphosphoglucuronateglucuronosyltransferase permits long-term, repeatable transgene expression in the Gunn rat model of Crigler-Najjar syndrome.
Thummala NR; Ghosh SS; Lee SW; Reddy B; Davidson A; Horwitz MS; Chowdhury JR; Chowdhury NR
Gene Ther; 2002 Aug; 9(15):981-90. PubMed ID: 12101428
[TBL] [Abstract][Full Text] [Related]
14. Persistent and secondary adenovirus-mediated hepatic gene expression using adenovirus vector containing CTLA4IgG.
Nakagawa I; Murakami M; Ijima K; Chikuma S; Saito I; Kanegae Y; Ishikura H; Yoshiki T; Okamoto H; Kitabatake A; Uede T
Hum Gene Ther; 1998 Aug; 9(12):1739-45. PubMed ID: 9721084
[TBL] [Abstract][Full Text] [Related]
15. Local gene therapy with CTLA4-immunoglobulin fusion protein in experimental allergic encephalomyelitis.
Croxford JL; O'Neill JK; Ali RR; Browne K; Byrnes AP; Dallman MJ; Wood MJ; Fedlmann M; Baker D
Eur J Immunol; 1998 Dec; 28(12):3904-16. PubMed ID: 9862327
[TBL] [Abstract][Full Text] [Related]
16. Transient immunomodulation with anti-CD40 ligand antibody and CTLA4Ig enhances persistence and secondary adenovirus-mediated gene transfer into mouse liver.
Kay MA; Meuse L; Gown AM; Linsley P; Hollenbaugh D; Aruffo A; Ochs HD; Wilson CB
Proc Natl Acad Sci U S A; 1997 Apr; 94(9):4686-91. PubMed ID: 9114052
[TBL] [Abstract][Full Text] [Related]
17. Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses.
Worgall S; Busch A; Rivara M; Bonnyay D; Leopold PL; Merritt R; Hackett NR; Rovelink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG
J Virol; 2004 Mar; 78(5):2572-80. PubMed ID: 14963160
[TBL] [Abstract][Full Text] [Related]
18. Blunting of immune responses to adenoviral vectors in mouse liver and lung with CTLA4Ig.
Jooss K; Turka LA; Wilson JM
Gene Ther; 1998 Mar; 5(3):309-19. PubMed ID: 9614550
[TBL] [Abstract][Full Text] [Related]
19. Tolerance to cardiac allografts via local and systemic mechanisms after adenovirus-mediated CTLA4Ig expression.
Guillot C; Mathieu P; Coathalem H; Le Mauff B; Castro MG; Tesson L; Usal C; Laumonier T; Brouard S; Soulillou JP; Lowenstein PR; Cuturi MC; Anegon I
J Immunol; 2000 May; 164(10):5258-68. PubMed ID: 10799887
[TBL] [Abstract][Full Text] [Related]
20. Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors.
Morral N; O'Neal W; Zhou H; Langston C; Beaudet A
Hum Gene Ther; 1997 Jul; 8(10):1275-86. PubMed ID: 9215744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
